Amount raised
$173M
Round
Series A
Date raised
November 17, 2026
Founded
—
CompanyMarrow Therapeutics
IndustryBiotechnology
InvestorsScion Life Sciences, venBio
Websitewww.marrowtx.com
Founders
- Gabriel MullokandovCo-founder
- Romesh SubramanianCo-founder & CEO
Get new raises like this every week
Free weekly list of newly funded startups and their founders.
About Marrow Therapeutics
an experimental treatment for sickle cell disease and beta thalassemia that aims to deliver genetic medicines directly to bone marrow cells.
- How much did Marrow Therapeutics raise?
- Marrow Therapeutics raised $173M in a Series A round on November 17, 2026. Investors include Scion Life Sciences, venBio.
- Who founded Marrow Therapeutics?
- Gabriel Mullokandov and Romesh Subramanian co-founded Marrow Therapeutics.